Wai Chun Bio-Technology Limited

660 KYG9450C1107

Specialty Chemicals

Delayed Hong Kong S.E. Other stock markets 09:08:08 27/06/2024 BST			5-day change	1st Jan Change
0.125 ^HKD	0.00%		0.00%	-13.19%

05-31	Wai Chun Bio-Technology Limited Announces Appointment of Fenn David as the Company Secretary, Effective June 1 ,2024	CI
05-21	Wai Chun Bio-Technology Limited Announces Resignation of Lam Kai Kei as Company Secretary and Authorised Representative	CI

Wai Chun Bio-Technology Limited Announces Resignation of Lam Kai Kei as Company Secretary and Authorised Representative

May 21, 2024 at 11:06 am

Wai Chun Bio-Technology Limited announced that, with effect from 21 May 2024, Mr. Lam Kai Kei ("Mr. Lam") resigned as the Company Secretary and Authorised Representative of the Company.

Latest news about Wai Chun Bio-Technology Limited

Wai Chun Bio-Technology Limited Announces Appointment of Fenn David as the Company Secretary, Effective June 1 ,2024	05-31	CI
Wai Chun Bio-Technology Limited Announces Resignation of Lam Kai Kei as Company Secretary and Authorised Representative	05-21	CI
Wai Chun Bio-Technology Limited Announces Change of Independent Non-Executive Director	04-01	CI
Wai Chun Bio-Technology Limited Announces Company Secretary Changes	03-28	CI
Wai Chun Bio-Technology's Fiscal H1 Attributable Loss Narrows	03-01	MT
Wai Chun Bio-Technology Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-29	CI
Wai Chun Bio-Technology Limited Announces Change of Company Secretary and Authorised Representative	02-15	CI
Winding-Up Petition Against Wai Chun Bio-Technology Withdrawn	12-11	MT
Wai Chun Bio-Technology Names Controlling Shareholder's Son as Chairman/CEO	11-02	MT
Wai Chun Bio-Technology Limited Announces Appointment of Lam Ka Chun as Chief Executive Officer	11-02	CI
Wai Chun Bio-Technology Limited Announces Appointment of Lam Ka Chun as Chairman of the Board	11-02	CI
Wai Chun Bio-Technology Incurs Loss in Fiscal Year 2023	29/09/23	MT
Wai Chun Bio-Technology Limited Reports Earnings Results for the Full Year Ended June 30, 2023	29/09/23	CI
Wai Chun Bio-Technology Limited Announces Board Changes	09/08/23	CI
Wai Chun Bio-Technology Limited Announces Change of Company Secretary and Authorised Representative	14/07/23	CI
Wai Chun Bio-Technology Limited Announces Change of Head Office and Principal Place of Business in Hong Kong	29/03/23	CI
Wai Chun Bio-Technology Limited Announces Management Changes	13/03/23	CI
Wai Chun Bio-Technology's H2 2022 Loss Widens	01/03/23	MT
Wai Chun Bio-Technology Limited Reports Earnings Results for the Half Year Ended December 31, 2022	28/02/23	CI
Wai Chun Bio-Technology Limited Announces Executive Changes	09/01/23	CI
Wai Chun Bio-Technology Limited Auditor Raises 'Going Concern' Doubt	27/11/22	CI
Wai Chun Bio-Technology to Widen Loss during 18 Months Ended June 30	08/11/22	MT
Wai Chun Bio-Technology Limited Provides Earning Guidance for Eighteen Months Ended 30 June 2022	08/11/22	CI
Wai Chun Bio-Technology Limited Announces Delay in Publication of the Audited Annual Results and Annual Report	21/10/22	CI
Wai Chun Bio-Technology Limited Announces Board Changes	10/10/22	CI

Chart Wai Chun Bio-Technology Limited

Duration

Period

More charts

Wai Chun Bio-Technology Ltd is a Hong Kong-based investment holding company principally engaged in the manufacture and sale of modified starch. Together with its subsidiaries, the Company is principally involved in the manufacture and sale of modified starch and other biochemical products, , such as biochemical refined oil products. In addition, the Company is also involved in the trading of electronic parts, components and electrical appliances.

Sector

Specialty Chemicals

Calendar

29/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Industrial Biotechnology Chemicals

	1st Jan change	Capi.
WAI CHUN BIO-TECHNOLOGY LIMITED	-13.19%	2.74M
NOVONESIS A/S	+16.33%	28.73B
BORREGAARD ASA	+14.35%	1.8B
PUYANG HUICHENG ELECTRONIC MATERIAL CO., LTD.	-22.35%	574M
HENAN JINDAN LACTIC ACID TECHNOLOGY CO.,LTD.	-30.46%	381M
BIO-ON S.P.A.	-81.65%	216M
CHEMCON SPECIALITY CHEMICALS LIMITED	-11.89%	115M